102PTargeting human CD141+ DC using CLEC9A antibodies for cancer immunotherapy. (17th December 2018) - Masterman, K-A; Pearson, F E; Tullett, K; Haigh, O; Walpole, C; Daraj, G; Lahoud, M H; Leal Rojas, I; Radford, K